Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in perioperative sedation, analgesia, and intrapulmonary shunt during lobectomy
ChiCTR-IPR-15006727Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in postoperative pain and procedural sedation and analgesia (PSA) (3 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: vital signs, BIS and 9 more. Planned start Jul 2015; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painprocedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR-IPR-15006727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006727.